Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | PNP |
Description | Menu Home About Technology Technology How It Works Key Studies Summary of the E. coli PNP System Cancer Targets Publications Patents Clinical Trials Inves |
Keywords | N/A |
WebSite | pnptherapeutics.com |
Host IP | 64.71.35.67 |
Location | United States |
Site | Rank |
US$3,432,096
Last updated: 2023-05-14 00:42:01
pnptherapeutics.com has Semrush global rank of 3,083,919. pnptherapeutics.com has an estimated worth of US$ 3,432,096, based on its estimated Ads revenue. pnptherapeutics.com receives approximately 396,011 unique visitors each day. Its web server is located in United States, with IP address 64.71.35.67. According to SiteAdvisor, pnptherapeutics.com is safe to visit. |
Purchase/Sale Value | US$3,432,096 |
Daily Ads Revenue | US$3,169 |
Monthly Ads Revenue | US$95,043 |
Yearly Ads Revenue | US$1,140,512 |
Daily Unique Visitors | 26,401 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
pnptherapeutics.com. | A | 14400 | IP: 64.71.35.67 |
pnptherapeutics.com. | NS | 14400 | NS Record: a.dns.hostway.net. |
pnptherapeutics.com. | NS | 14400 | NS Record: b.dns.hostway.net. |
pnptherapeutics.com. | MX | 14400 | MX Record: 10 mail.pnptherapeutics.com. |
Menu Home About Technology Technology How It Works Key Studies Summary of the E. coli PNP System Cancer Targets Publications Patents Clinical Trials Investor Relations News & Events Contact A new direction in cancer therapeutics A new direction in cancer therapeutics A new direction in cancer therapeutics E. coli purine nucleoside phosphorylase PNP Therapeutics PNP Therapeutics ® , Inc. is a clinical-stage, biopharmaceutical company engaged in the development of a platform technology (Gedeptin ® ) and proprietary products for the treatment of cancer. Learn more about PNP Therapeutics > . On September 28, 2021, PNP entered into an Assignment and License Agreement with GeoVax, Inc., whereby GeoVax obtained an exclusive license to PNP’s intellectual property and related assets associated with Gedeptin ® . All inquiries concerning Gedeptin ® should now be directed to GeoVax . News & Events September 28, 2021 > - PNP Therapeutics Licenses IP and Related Assets to GeoVax June 16, 2015 |
HTTP/1.1 200 OK Date: Wed, 22 Dec 2021 10:52:05 GMT Server: Apache Last-Modified: Tue, 30 Nov 2021 19:07:03 GMT ETag: "28ca-5d206433b76a9" Accept-Ranges: bytes Content-Length: 10442 Vary: Accept-Encoding Content-Type: text/html |
Domain Name: PNPTHERAPEUTICS.COM Registry Domain ID: 45821334_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2019-08-19T17:39:29Z Creation Date: 2000-12-02T07:15:01Z Registry Expiry Date: 2024-12-02T07:15:01Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: abuse@web.com Registrar Abuse Contact Phone: +1.8003337680 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: A.DNS.HOSTWAY.NET Name Server: B.DNS.HOSTWAY.NET DNSSEC: unsigned >>> Last update of whois database: 2021-12-25T08:16:07Z <<< |